| Financial Year |
March 31 2023 |
| Monetary Funds |
32,638,728,000.00 |
| Held-for-trading Financial Assets |
3,127,000.00 |
| Notes Receivable |
66,864,000.00 |
| Accounts Receivable |
2,754,064,000.00 |
| Advances to Suppliers |
534,029,000.00 |
| Other Receivables |
3,278,291,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,291,223,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,872,895,000.00 |
| Total Current Assets |
45,439,221,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
554,211,000.00 |
| Long-term Equity Investment |
16,657,070,000.00 |
| Investment Properties |
360,522,000.00 |
| Fixed Assetes |
91,209,224,000.00 |
| Under-construction Projects |
38,344,929,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,851,646,000.00 |
| R&D expenses |
-- |
| Goodwill |
1,102,185,000.00 |
| Long-Term Deferred and Prepaid Expenses |
263,409,000.00 |
| Deferred Income Tax Assets |
13,718,562,000.00 |
| Other Non-Current Assets |
7,198,000.00 |
| Sub-Total of Non-Current Assets |
299,713,421,000.00 |
| Total Assets |
345,152,642,000.00 |
| Short-Term Loans |
32,133,910,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
514,038,000.00 |
| Accounts Payable |
18,652,262,000.00 |
| Accounts Received In Advance |
58,970,000.00 |
| Employee Compensation Payable |
4,597,600,000.00 |
| Taxes Payable |
309,667,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,364,466,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,636,942,000.00 |
| Other Current Liabilities |
6,248,419,000.00 |
| Sub-Total of Current Liabilities |
113,945,282,000.00 |
| Long-term Loans |
76,414,970,000.00 |
| Bonds Payable |
11,194,159,000.00 |
| Long-Term Accounts Payable |
27,288,413,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,259,841,000.00 |
| Deferred Income Tax Liabilities |
589,095,000.00 |
| Other Non-Current Liabilities |
1,422,288,000.00 |
| Sub-Total of Non-Current Liabilities |
201,865,394,000.00 |
| Total Liabilities |
315,810,676,000.00 |
| Paid-In Capital(Or Share Stock) |
16,200,793,000.00 |
| Capital Surplus |
39,587,880,000.00 |
| Surplus Reserve |
11,564,287,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-32,089,267,000.00 |
| Minority Stockholder's Interest |
-5,983,764,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
35,325,730,000.00 |
| Owner's Equity（Stockholder's Equity） |
29,341,966,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
345,152,642,000.00 |
